Medical Safety News

  • Home
  • Medical Safety News

Medical Safety News The latest medical research, dietary supplement reports, FDA recalls and much more!

Unipharma, the company heavily promoted by an explant "concierge" to women with BII, has filed for Chapter 11 bankruptcy...
02/02/2021

Unipharma, the company heavily promoted by an explant "concierge" to women with BII, has filed for Chapter 11 bankruptcy after years of battles with the FDA over contaminated medicines, including the product Glutadose which was distributed across the US to explant patients and turned out to be contaminated by very serious bacteria. Many women reported getting very ill after being given Glutadose for detox for sick BII ladies.

--- PLEASE SHARE --- Another recent FDA Warning Letter has been submitted to us concerning Unipharma, LLC, the maker of ...
26/12/2019

--- PLEASE SHARE ---

Another recent FDA Warning Letter has been submitted to us concerning Unipharma, LLC, the maker of the recalled GLUTADOSE. On 11/06/2019, the FDA noted: "The pretreatment portion also had too numerous to count (TNTC) levels of microorganisms on multiple occasions."

This is very important information because the plant was found dirty and full of Burkholderia cepacia in the central water supply from which all medications were made. Unipharma made CVS Children's cough and cold products in the same vials it packed the Glutadose in and the children's medications had been contaminated and a total of six products by Unipharma recalled. Glutadose was the seventh recall and handled separately because it is a dietary supplement which is handled by cGMP practices instead of being considered a pharmaceutical. This means that it is largely exempt from inspections but because the entire water supply of the manufacturing plant was contaminated with Burkholderia cepacia (a former Pseudomonas strain), the Glutadose which was made with the same unsanitary water was also recalled.

The Unipharma plant had been found dirty from late 2018 until Nov. 2019 and FDA considered this information to be current as of 12/17/2019. This means that potentially ANY AND ALL Glutadose on the market ever made is potentially contaminated because the plant is still not cleaned up as of 12/17/2019.

https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/unipharma-llc-585388-11062019

Leviteracetam oral medicine recalled due to bacteria in the liquid.  https://www.fda.gov/safety/recalls-market-withdrawa...
20/12/2019

Leviteracetam oral medicine recalled due to bacteria in the liquid.

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/lannett-issues-voluntary-nationwide-recall-levetiracetam-oral-solution-100mgml-due-microbial?utm_campaign=Lannett%20Issues%20Voluntary%20Nationwide%20Recall%20of%20Levetiracetam%20Oral%20Solution%2C%20100mg%2FMl&utm_medium=email&utm_source=Eloqua

Lannett Company, Inc. today announced that it is voluntarily recalling two (2) lots of Levetiracetam Oral Solution, 100mg/mL to the consumer level due to contamination with Bacillus subtilis. The Bacillus subtilis was identified during an evaluation of a raw material used to manufacture the product

The same Barry's Herb and Vitamin Shop where the fake doctors Arrieta and Barry Nevins were arrested also sold male enha...
18/12/2019

The same Barry's Herb and Vitamin Shop where the fake doctors Arrieta and Barry Nevins were arrested also sold male enhancement drugs named Virility Max with illegal pharma ingredients and was forced to recall them by FDA around the same time some of their employees were arrested for impersonating doctors. Employees of the shop were Barry Nevins, Jeff Rose, Edgar Arrieta.

https://www.sun-sentinel.com/health/fl-xpm-2011-11-14-fl-hk-virility-max-recall-20111114-story.html

https://www.ksdk.com/article/news/makers-of-tainted-supplements-have-criminal-pasts/63-308556770?fbclid=IwAR3VKyFn_6QiFLFxW-0kNIyyeMwGLuTDq7TpJkqdQQ6h7034QH7e-zwNPR4

***BREAKING NEWS ON GLUTADOSE ***"Dr.Glutadose" fraudulent scientist "Dr." Edgar Arrieta" was arrested in the past for p...
12/12/2019

***BREAKING NEWS ON GLUTADOSE ***

"Dr.Glutadose" fraudulent scientist "Dr." Edgar Arrieta" was arrested in the past for playing doctor while marketing dietary supplements, was recently again introduced via FB Live as "Dr. Edgar Arrieta, the scientist who developed glutadose".

Beware of false claims on social media! This one was entirely false and fraudulent, as it turned out. Arrieta is NOT a doctor of any kind despite being sold by his co-conspirators online as "Dr. Arrieta" in 2019 again. Please check your Glutadose supply against FDA recall list.

https://www.sun-sentinel.com/news/florida/sfl-vitamin-shop-20111016-story.html?fbclid=IwAR2oaumA3i1uAozuLDBvkhFBPuxxWcSj3MeIws06-0zsh82XGo_MmhmOq_A

From last month, but these are the most recent class I (most serious) FDA recalls.  After a recall is initiated, the FDA...
03/12/2019

From last month, but these are the most recent class I (most serious) FDA recalls. After a recall is initiated, the FDA classifies it according to severity. Class I is most serious, class II is still moderate risk with class III being the lightest. Below are the classifications for last month's most serious recalls, from contaminated medication lots to medical devices.
https://www.fiercebiotech.com/medtech/fda-ranks-separate-recalls-from-abbott-philips-as-class-i

The FDA recently labeled two device recalls as Class I, the most serious, after they were launched by Philips and Abbott earlier this year—including the latter’s CentriMag cardiac support system for open-heart surgeries following the death of a patient. Meanwhile, Philips Medical Systems (Clevel...

Recalled Glutadose distributed on FB under this post on July 14, 2019.  Note the recalled lot  #90013.
28/11/2019

Recalled Glutadose distributed on FB under this post on July 14, 2019. Note the recalled lot #90013.

****** FDA advisory on the risk of Burkholderia cepacia in liquid solutions below. ****** " The FDA advises drug manufac...
28/11/2019

****** FDA advisory on the risk of Burkholderia cepacia in liquid solutions below. ******

" The FDA advises drug manufacturers of non-sterile, water-based drug products that there have been recent product recalls due to Burkholderia cepacia complex (BCC or B. cepacia) contamination.(1, 2, 3) BCC and other water-borne opportunistic pathogens are among the contaminants that can be found in pharmaceutical water systems.

BCC can survive or multiply in a variety of non-sterile and water-based products because it is resistant to certain preservatives and antimicrobial agents.(4, 5) Detecting BCC bacteria is also a challenge and requires validated testing methods that take into consideration the unique characteristics of different BCC strains.

People exposed to BCC are at an increased risk for illness or infection, especially patients with compromised immune systems.(3, 6)"

https://www.fda.gov/drugs/drug-safety-and-availability/fda-advises-drug-manufacturers-burkholderia-cepacia-complex-poses-contamination-risk-non-sterile

This page covers the topics of b. cepacia, BCC, burkholderia cepacia complex in drug manufaturing.

25/11/2019

We are happy to support this petition:
Please sign our petition and we are close to launching our project! - Valerie Lenie
https://www.change.org/.../a-demand-to-investigate-the...

Change.org is the web's leading platform for social change, empowering anyone, anywhere to start petitions that make a difference.

Recall on stomach medicine ranitidine due to cancer-causing agents polluting this oral solution.   https://www.fda.gov/s...
21/11/2019

Recall on stomach medicine ranitidine due to cancer-causing agents polluting this oral solution.

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/precision-dose-inc-issues-voluntary-nationwide-recall-ranitidine-oral-solution-usp-150-mg10-ml-due?utm_campaign=FDA%20MedWatch%20-%20Ranitidine%20Oral%20Solution%20by%20Precision%20Dose%3A%20Recall&utm_medium=email&utm_source=Eloqua

Precision Dose Inc. is voluntarily recalling 5 lots of Ranitidine Oral Solution, USP 150 mg/10 mL to the consumer level. Ranitidine Oral Solution, USP 150 mg/10 mL, is being recalled because of potential N-Nitrosodimethylamine (NDMA) amounts above levels established by the FDA.

Address


Website

Alerts

Be the first to know and let us send you an email when Medical Safety News posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

  • Address
  • Alerts
  • Claim ownership or report listing
  • Want your business to be the top-listed Media Company?

Share